Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for GNT Pharma

    Client Virtual Booth

    GNT PHARMA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    GNT Pharma
    korearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    1855-23 Yonggudae-ro, Giheung-gu, Yongin-si, Gyeonggi-do, 17096
    Telephone
    Telephone
    031-8005-9910
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://gntpharma.com/en/home_en/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    GNT Pharma Announces Approval of IND for PIII Trial of Nelonemdaz
    GNT Pharma Announces Approval of IND for PIII Trial of Nelonemdaz

    https://www.globenewswire.com/news-release/2021/09/08/2293151/0/en/GNT-Pharma-Announces-Approval-of-IND-Application-for-the-Phase-III-RODIN-Trial-of-Nelonemdaz-for-Acute-Ischemic-Stroke-Patients.html

    GLOBENEWSWIRE
    08 Sep 2021
    Share Share
    GNT Eyes Unmet Need As Novel Ischemic Stroke Therapy Moves To Phase III
    GNT Eyes Unmet Need As Novel Ischemic Stroke Therapy Moves To Phase III

    https://scrip.pharmaintelligence.informa.com/SC144984/GNT-Eyes-Unmet-Need-As-Novel-Ischemic-Stroke-Therapy-Moves-To-Phase-III

    Jung Won Shin PHARMA INTELLIGENCE
    31 Aug 2021
    Share Share
    GNT Pharma Announces Positive Top-Line Results in a Phase II Study of Nelonemdaz
    GNT Pharma Announces Positive Top-Line Results in a Phase II Study of Nelonemdaz

    https://www.businesswire.com/news/home/20201014005333/en/GNT-Pharma-Announces-Positive-Top-Line-Results-in-a-Phase-II-Study-of-Nelonemdaz-for-Acute-Ischemic-Stroke-Patients-Treated-With-Endovascular-Thrombectomy

    BUSINESSWIRE
    14 Oct 2020
    Share Share
    GNT Pharma Announces Positive Top-Line Results in a Phase II Study
    GNT Pharma Announces Positive Top-Line Results in a Phase II Study

    https://www.businesswire.com/news/home/20201014005333/en

    BUSINESSWIRE
    14 Oct 2020
    Share Share
    GNT Pharma Announces Positive Top-Line Results in a Phase II Study of Nelonemdaz
    GNT Pharma Announces Positive Top-Line Results in a Phase II Study of Nelonemdaz

    https://www.afp.com/en/news/1314/gnt-pharma-announces-positive-top-line-results-phase-ii-study-nelonemdaz-acute-ischemic-stroke-patients-treated-endovascular-thrombectomy-202010140053331

    AFP
    14 Oct 2020
    Share Share
    Distributed Bio Collaborates With Washington University School of Medicine
    Distributed Bio Collaborates With Washington University School of Medicine

    https://www.businesswire.com/news/home/20200114005196/en

    BUSINESS WIRE
    14 Jan 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search